Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study
Boukje C. Eveleens Maarse(Leiden University Medical Center), Sherin Manan, Robbert W. Schouten, Nicholas C Chesnaye(Amsterdam Neuroscience), Hans Schmidt-Gürtler, Christian Marx, Yvette Meuleman(Leiden University Medical Center), Claudia Emde(Ludwig-Maximilians-Universität München), Justyna Mazur, Ines Schlee, Sabine Aign, Kirsten Anding‐Rost, Katja Blouin, Holger Naujoks, Christoph Wanner(Universitätsklinikum Würzburg), Magdalena Krajewska(Wrocław University of Science and Technology), Eva Platen, Marie Evans(Karolinska University Hospital), Willem Jan W. Bos(St. Antonius Ziekenhuis), Monika Hopf, Pawlos Ichtiaris, Olof Heimbürger(Karolinska University Hospital), Kitty J. Jager(Amsterdam University Medical Centers), Katrin Neumeier, Christiane Drechsler(Universitätsklinikum Würzburg), Petra Kirste, Sabine Cäsar, Nikolaus Frischmuth, Jochen Röthele, Petra Schulz, Sandra Biribauer, Hendrik Schlee, Wieneke M. Michels(Leiden University Medical Center), Boris Perras, Dunja Fuchs, Beate Iwig, Joachim Beige, Nadja Wuttke, Maciej Szymczak(Wroclaw Medical University), Friedo W. Dekker(Leiden University Medical Center), Fergus Caskey, Christof Blaser, Detlef H. Krieter(Universitätsklinikum Würzburg), Andreas Schneider, Lothar Schramm, Ellen Irmler, Kai Hahn, Anke Torp
Cited by 17
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
|Kidney International|1999|1.8k
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly
|Kidney International|2005|927